Home
Conditions
Demyelinating Diseases

Clinical trial condition

Demyelinating Diseases

Explore clinical trials studying Demyelinating Diseases. Study availability and eligibility vary by location and protocol.

2,931 public trials 462 recruiting studies

Refine in advanced search Browse all conditions

Demyelinating Diseases trial results

Completed

A Study to Evaluate Readiness to Self-inject on Adherence and Compliance to Copaxone® Therapy

NCT00238654

Conditions: Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Demyelinating Autoimmune Diseases, CNS, +4 more
Locations: Not specified

View Trial Details

Completed

A Study Comparing Shared Solutions® Plus MS Center Support Versus Shared Solutions® Alone

NCT00240006

Conditions: Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Demyelinating Autoimmune Diseases, CNS, +4 more
Locations: Not specified

View Trial Details

Completed

A Study to Evaluate the Impact on Skin (Injection Site) Reactions of Taking an Antihistamine (Zyrtec®) or Placebo Prior to Daily Injections of Copaxone®.

NCT00240032

Conditions: Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Demyelinating Autoimmune Diseases, CNS, +4 more
Locations: Not specified

View Trial Details

Completed

A Study to Evaluate the Impact on Skin (Injection Site) Reactions of Using Alcohol Wipes Prior to Daily Injections of Copaxone®.

NCT00220922

Conditions: Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Demyelinating Autoimmune Diseases, CNS, +4 more
Locations: Not specified

View Trial Details

Completed

A Study to Evaluate the Effectiveness, Tolerability and Safety of Laquinimod

NCT00349193

Conditions: Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Demyelinating Autoimmune Diseases, CNS, +6 more
Locations: Not specified

View Trial Details

Completed

Success of Titration, Analgesics, and B.E.T.A Nurse Support on Acceptance Rates in Early Multiple Sclerosis (MS) Treatment With Betaseron

NCT00461396

Conditions: Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Demyelinating Autoimmune Diseases, CNS, +5 more
Locations: Many Locations, Alabama, United States

Many Locations, Arizona, United States

Many Locations, Delaware, United States

Many Locations, District of Columbia, United States

View all 19 locations

View Trial Details

Completed

The Effectiveness of Locomotor Therapy Using Robot-Driven Gait Orthosis System in Multiple Sclerosis Patients

NCT00843128

Conditions: Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Demyelinating Autoimmune Diseases, CNS, +4 more
Locations: Hadassah University Hospital Jerusalem, Israel

View Trial Details

Completed

Biomarkers and Response to Natalizumab for Multiple Sclerosis Treatment

NCT00942214

Conditions: Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Demyelinating Autoimmune Diseases, CNS, +4 more
Locations: service de neurologie, hôpital Purpan Toulouse, France

View Trial Details

Completed

Effect of Warfarin in the Treatment of Metachromatic Leukodystrophy

NCT00683189

Conditions: Brain Diseases, Brain Diseases, Metabolic, Brain Diseases, Metabolic, Inborn, +19 more
Locations: Cooper University Hospital Camden, New Jersey, United States

View Trial Details

Completed

12-week Safety Evaluation of Oral CS-0777 in Multiple Sclerosis Patients

NCT00616733

Conditions: Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Demyelinating Autoimmune Diseases, CNS, +8 more
Locations: Denver, Colorado, United States

Port Orange, Florida, United States

Lenexa, Kansas, United States

Billings, Montana, United States

View Trial Details

Demyelinating Diseases

Demyelinating Diseases trial results

Related conditions